pirke / Shutterstock.com
26 March 2024NewsMedtechMarisa Woutersen

Judge tears into ‘safe harbour’ ruling in heart valve system case

Judge’s dissenting opinion challenges the interpretation of the safe harbour provision by the US Court of Appeals for the Federal Circuit | Decision concerns Meril's importation of transcatheter heart valve systems in a dispute with Edwards Lifesciences | Court majority upheld the district court's ruling favouring Meril.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.
Medtech
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.

More on this story

Americas
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.
Medtech
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.

More on this story

Americas
16 October 2020   A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.
Medtech
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.